C85.24
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Mediastinal (thymic) large B-cell lymphoma is a specific type of non-Hodgkin lymphoma that primarily affects the lymphatic tissue in the mediastinum, which is the central part of the chest cavity. This form of lymphoma involves large B-cells, a type of white blood cell that plays a vital role in the immune system. It often originates in the thymus gland located in the mediastinum but can also involve nearby lymph nodes, especially those in the axilla (underarm) and upper limb regions. Understanding this condition can help patients recognize its features and the importance of medical attention for diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal B-cell growth Exposure to certain chemicals or environmental toxins Suppressed immune system due to medical conditions or medications Previous radiation therapy in the chest area Unknown factors, as specific causes are often not identifiable
Key Symptoms: Persistent chest pain or discomfort Swelling or a mass in the chest area Shortness of breath or difficulty breathing Unexplained weight loss Fever and night sweats Swollen lymph nodes in the armpits and upper limbs Fatigue and general weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosing mediastinal large B-cell lymphoma includes a combination of medical assessments and tests such as: - Physical examination to check for enlarged lymph nodes and other symptoms - Imaging studies like chest X-rays, CT scans, or PET scans to visualize the mediastinal region and lymph nodes - Biopsy procedures where a tissue sample from the suspected lymph node or mediastinal mass is collected and examined microscopically - Blood tests to evaluate overall health and organ function - Additional tests such as bone marrow biopsy may be performed if the disease is suspected to have spread
Treatment Protocols: Treatment options typically involve multidisciplinary approaches, including: - Chemotherapy to target cancerous B-cells - Radiation therapy aimed at specific regions of the mediastinum or affected lymph nodes - Targeted therapy that focuses on specific molecules involved in the lymphoma's growth - Immunotherapy to enhance the body's immune response against cancer cells - Stem cell transplant may be considered in certain cases where other treatments have been effective The treatment plan is customized based on factors such as stage of the disease, overall health, and response to initial therapies.
Clinical Advice & FAQs
Billing Guidance
Is C85.24 a billable ICD-10 code?
Yes, C85.24 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.24?
Clinical documentation must specify the nature of Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference